keyword
https://read.qxmd.com/read/38637820/neoadjuvant-chemotherapy-does-not-improve-survival-for-patients-with-high-volume-colorectal-peritoneal-metastases-undergoing-cytoreductive-surgery
#1
JOURNAL ARTICLE
Mina Sarofim, Ruwanthi Wijayawardana, Nima Ahmadi, Shoma Barat, Winston Liauw, David L Morris
BACKGROUND: Colorectal peritoneal metastases (CRPM) affects 15% of patients at initial colorectal cancer diagnosis. Neoadjuvant chemotherapy (NAC) prior to cytoreductive surgery (CRS) has been demonstrated to be a safe and feasible option, however there is limited data describing its efficacy in advanced peritoneal disease. This study evaluated the effect of NAC on survival in patients with high volume CRPM undergoing CRS with or without HIPEC. METHODS: A retrospective review of all patients who underwent CRS with or without HIPEC for CRPM from 2004 to 2019 at our institution was performed...
April 18, 2024: World Journal of Surgical Oncology
https://read.qxmd.com/read/38627808/repeat-cytoreductive-surgery-with-hipec-for-colorectal-peritoneal-metastases-a-systematic-review
#2
REVIEW
Mina Sarofim, Ruwanthi Wijayawardana, Nima Ahmadi, David L Morris
BACKGROUND: Colorectal peritoneal metastases (CRPM) are present in 10-20% of patients at the time of their initial cancer diagnosis, and affects over 20% of those who develop colorectal cancer recurrence. Cytoreductive surgery (CRS) with HIPEC is firmly established as the optimal surgical treatment, but there is very little known about the benefit of repeat or iterative CRS. The aim of this review is to provide a systematic evaluation of the perioperative complications, survival outcomes and quality of life in patients undergoing repeat CRS with HIPEC for CRPM...
April 17, 2024: World Journal of Surgical Oncology
https://read.qxmd.com/read/38549002/should-cytoreductive-surgery-alone-for-peritoneal-metastases-of-colorectal-origin-be-centralized-a-national-study-of-4159-procedures
#3
JOURNAL ARTICLE
Barbara Noiret, Xavier Lenne, Amélie Bruandet, Guillaume Piessen, Clarisse Eveno
BACKGROUND: Addition of oxaliplatin-based hyperthermic intraperitoneal chemotherapy (HIPEC) to cytoreductive surgery (CRS) in the treatment of peritoneal metastases of colorectal origin (CRPM) did not show any survival benefit in the PRODIGE 7 trial (P7). This study aimed to investigate whether perioperative outcomes after CRS alone for CRPM patients is mediated by hospital volume and to determine the effect of P7 on French practice for CRPM patients treated respectively with CRS alone and CRS/HIPEC...
March 28, 2024: Annals of Surgical Oncology
https://read.qxmd.com/read/38346508/fabrication-of-crown-ether-containing-copolymer-porous-membrane-and-their-enhanced-adsorption-performance-for-cationic-dyes-experimental-and-dft-investigations
#4
JOURNAL ARTICLE
Meng Wang, Rongkang Yan, Meng Shan, Shasha Liu, Hai Tang
Adsorptive separation membranes are widely utilized for the removal of toxic dyeing pollutants from dyeing wastewater. However, developing novel adsorption membranes with large adsorption capacities and enhanced adsorption performance for dyes in actual wastewater poses a significant challenge. This study focuses on the fabrication of crown ether-containing copolymer porous membrane (CRPM) and investigation of the adsorption performance of dyes from aqueous solutions. The morphology structure and pore size distribution revealed that the membrane was endowed with rich micropores and hierarchical porous structures...
February 10, 2024: Chemosphere
https://read.qxmd.com/read/38310181/preoperative-ca-19-9-predicts-disease-progression-in-colorectal-peritoneal-metastases-treated-with-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemotherapy-an-analysis-from-the-us-hipec-collaborative
#5
JOURNAL ARTICLE
Nadege T Fackche, Ryan K Schmocker, Richard Nudotor, Boateng Kubi, Jordan M Cloyd, Travis E Grotz, Keith F Fournier, Sean P Dineen, Jula Veerapong, Joel M Baumgartner, Callisia N Clarke, Sameer H Patel, Gregory C Wilson, Laura A Lambert, Courtney Pokrzywa, Daniel E Abbott, Byrne Lee, Charles A Staley, Mohammad Y Zaidi, Fabian M Johnston, Jonathan B Greer
INTRODUCTION: Patients with colorectal peritoneal metastases (CRPM) are increasingly treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). Unfortunately, data identifying preoperative risk factors for poor oncologic outcomes after this procedure are limited. We aimed to determine the prognostic value of preoperative CEA, CA 125, and CA 19-9 on disease progression after CRS/HIPEC. METHODS: Patients with CRPM treated with curative intent CRS/HIPEC from 12 participating sites in the United States from 2000 to 2017 were identified...
February 3, 2024: Annals of Surgical Oncology
https://read.qxmd.com/read/38270826/normal-cea-levels-after-neoadjuvant-chemotherapy-and-cytoreduction-with-hyperthermic-intraperitoneal-chemoperfusion-predict-improved-survival-from-colorectal-peritoneal-metastases
#6
JOURNAL ARTICLE
Michael M Wach, Geoffrey Nunns, Ahmed Hamed, Joshua Derby, Mark Jelinek, Curtis Tatsuoka, Matthew P Holtzman, Amer H Zureikat, David L Bartlett, Steven A Ahrendt, James F Pingpank, M Haroon A Choudry, Melanie Ongchin
BACKGROUND: Normal carcinoembryonic antigen (CEA) levels (≤ 2.5 ng/ml) after resection of localized colorectal cancer or liver metastases are associated with improved survival, however, these trends are understudied for colorectal peritoneal metastases (CRPM). PATIENTS AND METHODS: We conducted a retrospective single-institution study of patients with CRPM undergoing cytoreductive surgery with hyperthermic intraperitoneal chemoperfusion (CRS/HIPEC) with and without neoadjuvant chemotherapy (NACT)...
April 2024: Annals of Surgical Oncology
https://read.qxmd.com/read/38269922/continuous-remote-patient-monitoring-for-post-discharge-heart-failure-management-workflow-modeling-using-discrete-event-simulation
#7
JOURNAL ARTICLE
Rema Padman, Anirudh Vaidhyaa Venkatasubramanian, Wei Ning Chi, Anthony Solomonides, Nirav Shah
The Cascade-HF protocol is a Continuous Remote Patient Monitoring (CRPM) study at a major health system in the United States to reduce Heart Failure (HF)-related hospitalizations and readmissions using wearable biosensors to collect physiological data over a 30-day period to determine decompensation risk among HF patients. The alerts produced, coupled with electronic patient-reported outcomes, are utilized daily by the home health team, and escalated to the heart failure team as needed, for proactive actions...
January 25, 2024: Studies in Health Technology and Informatics
https://read.qxmd.com/read/38238803/association-of-biochemical-markers-with-bone-marrow-lesion-changes-on-imaging-data-from-the-foundation-for-the-national-institutes-of-health-osteoarthritis-biomarkers-consortium
#8
JOURNAL ARTICLE
Shirley P Yu, Leticia A Deveza, Virginia B Kraus, Morten Karsdal, Anne-Christine Bay-Jensen, Jamie E Collins, Ali Guermazi, Frank W Roemer, Christoph Ladel, Venkatesha Bhagavath, David J Hunter
BACKGROUND: To assess the prognostic value of short-term change in biochemical markers as it relates to bone marrow lesions (BMLs) on MRI in knee osteoarthritis (OA) over 24 months and, furthermore, to assess the relationship between biochemical markers involved with tissue turnover and inflammation and BMLs on MRI. METHODS: Data from the Foundation for the National Institutes of Health OA Biomarkers Consortium within the Osteoarthritis Initiative (n = 600) was analyzed...
January 18, 2024: Arthritis Research & Therapy
https://read.qxmd.com/read/38062463/predictive-value-of-clinical-features-and-ct-radiomics-in-the-efficacy-of-hip-preservation-surgery-with-fibula-allograft
#9
JOURNAL ARTICLE
Peng Xue, Hongzhong Xi, Hao Chen, Shuai He, Xin Liu, Bin Du
BACKGROUND: Despite being an effective treatment for osteonecrosis of the femoral head (ONFH), hip preservation surgery with fibula allograft (HPS&FA) still experiences numerous failures. Developing a prediction model based on clinical and radiomics predictors holds promise for addressing this issue. METHODS: This study included 112 ONFH patients who underwent HPS&FA and were randomly divided into training and validation cohorts. Clinical data were collected, and clinically significant predictors were identified using univariate and multivariate analyses to develop a clinical prediction model (CPM)...
December 8, 2023: Journal of Orthopaedic Surgery and Research
https://read.qxmd.com/read/37823436/primary-tumor-resection-improves-prognosis-of-unresectable-carcinomas-of-the-transverse-colon-including-flexures-with-pulmonary-metastasis-a-cohort-study
#10
JOURNAL ARTICLE
Huixia Zhao, Guangze Song, Ruliang Wang, Na Guan, Chao Yun, Jingwen Yang, Jin-Bao Ma, Hui Li, Wenhua Xiao, Liang Peng
PURPOSE: Studies of unresectable colorectal cancer pulmonary metastasis (CRPM) have rarely analyzed patient prognosis from the perspective of colonic subsites. This study aimed to evaluate the effects of primary tumor resection (PTR) on the prognosis of patients with unresectable pulmonary metastases of transverse colon cancer pulmonary metastasis (UTCPM), hepatic flexure cancer pulmonary metastasis (UHFPM), and splenic flexure cancer pulmonary metastasis (USFPM). METHODS: Patients were identified from the Surveillance, Epidemiology, and End Results database between 2000 and 2018...
October 9, 2023: European Journal of Cancer Prevention
https://read.qxmd.com/read/37693741/evaluating-an-advanced-practice-provider-managed-coronavirus-disease-2019-deterioration-program
#11
JOURNAL ARTICLE
Janey Kottler, Shaveta Khosla, Vicki Recio, David Chestek, Jacqueline Shanks, Karen Larimer, Terry Vanden Hoek
BACKGROUND: COVID-19 changed how healthcare systems could provide quality healthcare to patients, safely. An urban healthcare system created an advanced practice provider (APP)-managed continuous remote patient monitoring (cRPM) program. METHODS: A mixed-method study design focusing on the usable and feasible nature of the cRPM program. Both APP-guided interviews and online questionnaires were analyzed. RESULTS: There was overwhelmingly positive APP feedback utilizing the remote monitoring solution including providing quality healthcare, detecting early clinical deterioration, and desiring to adapt the solution to other acute or chronic diseases...
October 2023: Journal for Nurse Practitioners: JNP
https://read.qxmd.com/read/37626399/extracellular-matrix-turnover-biomarkers-reflect-pharmacodynamic-effects-and-treatment-response-of-adalimumab-in-patients-with-axial-spondyloarthritis-results-from-two-randomized-controlled-trials
#12
JOURNAL ARTICLE
Helena Port, Signe Holm Nielsen, Peder Frederiksen, Sofie Falkenløve Madsen, Anne-Christine Bay-Jensen, Inge Juul Sørensen, Bente Jensen, Anne Gitte Loft, Ole Rintek Madsen, Mikkel Østergaard, Susanne Juhl Pedersen
OBJECTIVE: To investigate if extracellular matrix (ECM) blood-based biomarkers reflect the pharmacodynamic effect and response to TNF-α inhibitor therapy (adalimumab, ADA), in patients with axial spondyloarthritis (axSpA). METHODS: We investigated ECM biomarkers in two randomized, double-blind, placebo-controlled trials of axSpA patients (DANISH and ASIM, n = 52 and n = 49, respectively) receiving ADA 40 mg or placebo every other week for 12 and 6 weeks, respectively, and thereafter ADA to week 48...
August 25, 2023: Arthritis Research & Therapy
https://read.qxmd.com/read/37602499/external-validation-of-prognostic-scores-and-comparison-of-predictive-accuracy-for-patients-with-colorectal-cancer-with-peritoneal-metastases-considered-for-cytoreductive-surgery-and-intraperitoneal-chemotherapy
#13
JOURNAL ARTICLE
Mathew A Kozman, Oliver M Fisher, Winston Liauw, David L Morris, Peter H Cashin
BACKGROUND AND OBJECTIVES: Prognostic scores are developed to facilitate the selection of patients with colorectal cancer peritoneal metastases (CRPM) for treatment with cytoreductive surgery (CRS) ± intraperitoneal chemotherapy (IPC). Three prominent prognostic scores are the Peritoneal Surface Disease Severity Score (PSDSS), the Colorectal Peritoneal Metastases Prognostic Surgical Score (COMPASS), and the modified COloREctal-Pc (mCOREP). We externally validate these scores and compare their predictive accuracy...
August 21, 2023: Journal of Surgical Oncology
https://read.qxmd.com/read/37537172/fdw028-a-novel-fut8-inhibitor-impels-lysosomal-proteolysis-of-b7-h3-via-chaperone-mediated-autophagy-pathway-and-exhibits-potent-efficacy-against-metastatic-colorectal-cancer
#14
JOURNAL ARTICLE
Mengmeng Wang, Zhoudong Zhang, Mengxi Chen, Yixin Lv, Sheng Tian, Fanyi Meng, Yawen Zhang, Xuqin Guo, Yinshuang Chen, Man Yang, Jiawei Li, Tian Qiu, Fang Xu, Zhi Li, Qi Zhang, Jie Yang, Jing Sun, Hongjian Zhang, Haiyang Zhang, Huanqiu Li, Weipeng Wang
Metastatic colorectal cancer (mCRC) is a major cause of cancer-related mortality due to the absence of effective therapeutics. Thus, it is urgent to discover new drugs for mCRC. Fucosyltransferase 8 (FUT8) is a potential therapeutic target with high level in most malignant cancers including CRC. FUT8 mediates the core fucosylation of CD276 (B7-H3), a key immune checkpoint molecule (ICM), in CRC. FUT8-silence-induced defucosylation at N104 on B7-H3 attracts heat shock protein family A member 8 (HSPA8, also known as HSC70) to bind with 106-110 SLRLQ motif and consequently propels lysosomal proteolysis of B7-H3 through the chaperone-mediated autophagy (CMA) pathway...
August 3, 2023: Cell Death & Disease
https://read.qxmd.com/read/37483317/healthcare-provider-experiences-of-deploying-a-continuous-remote-patient-monitoring-pilot-program-during-the-covid-19-pandemic-a-structured-qualitative-analysis
#15
JOURNAL ARTICLE
Juliana Pugmire, Matt Wilkes, Adam Wolfberg, Nicole Zahradka
OBJECTIVE: To describe the healthcare provider (HCP) experience of launching a COVID-19 remote patient monitoring (CRPM) program during the global COVID-19 pandemic. METHODS: We conducted qualitative, semi-structured interviews with eight HCPs involved in deploying the CRPM pilot program in the Military Health System (MHS) from June to December 2020. Interviews were audio recorded, transcribed, and analyzed thematically using an inductive approach. We then deductively mapped themes from interviews to the updated Consolidated Framework for Implementation Research (CFIR)...
2023: Frontiers in digital health
https://read.qxmd.com/read/37436640/role-of-circulating-tumor-dna-among-patients-with-colorectal-peritoneal-metastases
#16
REVIEW
Joel M Baumgartner, Gregory P Botta
PURPOSE: This was a review of circulating tumor DNA (ctDNA) in patients with peritoneal metastases from colorectal cancer. METHODS: We searched the PubMed database for studies reporting detection of ctDNA in patients with colorectal cancer (CRC) and with peritoneal metastases (PM) from colorectal cancer (CRPM). We extracted data on the population included, number of subjects, study design, type of ctDNA assay used and schedule, and the major findings from these publications...
July 12, 2023: Journal of Gastrointestinal Cancer
https://read.qxmd.com/read/37342785/pathological-tissue-formation-and-degradation-biomarkers-correlate-with-patient-reported-pain-outcomes-an-explorative-study
#17
JOURNAL ARTICLE
Anne C Bay-Jensen, Mukundan Attur, Jonathan Samuels, Christian S Thudium, Steven B Abramson, Morten A Karsdal
BACKGROUND: The lack of disease modifying drugs in Osteoarthritis (OA) may be attributed to the difficulty in robust response based on patient-reported outcomes (PROs) linked to drug mechanism of action. Joint tissue turnover biomarkers are associated with disease progression. A subset of patients has elevated serum levels of CRP metabolite (CRPM). This explorative study investigates the associations between PROs and joint tissue turnover markers in patients with high or low CRPM. METHODS: Serum of 146 knee OA patients of the New York Inflammation cohort and 21 healthy donors were assessed for biomarkers of collagen degradation (C1M, C2M, C3M, C4M), formation (PRO-C1, PRO-C2, PRO-C3, PRO-C4), and CRPM...
September 2023: Osteoarthritis and cartilage open
https://read.qxmd.com/read/37277038/health-risk-assessment-from-exposure-to-ambient-vocs-and-particulate-matter-in-different-functional-zones-in-dhanbad-india
#18
JOURNAL ARTICLE
Nidhi Malik, Suresh Pandian Elumalai, Krishan Kumar
This study evaluates the non-cancer risks (NCR) and cancer risks (CR) in outdoor working personnel in Dhanbad city, exposed to volatile organic compounds (VOCs) and particulate matter (PM) present in the ambient air. Dhanbad is known for its coal mines and is one of the most polluted cities in India and the world. Sampling was conducted in different functional zones; namely, traffic intersections, industrial, and institutional areas, to estimate the concentration of different PM-bound heavy metals and VOCs in the ambient air using Inductively coupled plasma-optical emission spectrometry (ICP-OES) and gas chromatography (GC) respectively...
June 3, 2023: Science of the Total Environment
https://read.qxmd.com/read/37085655/impact-of-primary-tumor-location-and-genomic-alterations-on-survival-following-cytoreductive-surgery-and-hyperthermic-intraperitoneal-chemoperfusion-for-colorectal-peritoneal-metastases
#19
JOURNAL ARTICLE
Ahmed B Hamed, Yongli Shuai, Joshua Derby, Matthew P Holtzman, Melanie Ongchin, David L Bartlett, James F Pingpank, Reetesh Pai, Aatur Singhi, Haroon A Choudry
BACKGROUND: Colorectal cancer leads to peritoneal metastases (CRPM) in 10% of cases. Cytoreductive surgery with hyperthermic intraperitoneal chemoperfusion (CRS-HIPEC) improves survival. Primary tumor location and abnormalities in RAS, BRAF, and mismatch repair/microsatellite stability (MMR/MSI) may affect post-CRS-HIPEC survival, but studies have not been consistent. We estimated the effects of primary tumor site and genomic alterations on post-CRS-HIPEC survival. METHODS: This retrospective cohort study included CRS-HIPEC cases for CRPM at a high-volume center from 2001 to 2020...
April 21, 2023: Annals of Surgical Oncology
https://read.qxmd.com/read/37020095/use-of-prognostic-factors-and-scores-in-selection-of-patients-with-colorectal-cancer-peritoneal-metastasis-crpm-for-cytoreductive-surgery-and-intraperitoneal-chemotherapy-crs-ipc-results-of-an-international-survey-among-oncologic-clinicians
#20
JOURNAL ARTICLE
Mathew A Kozman, Oliver M Fisher, Winston Liauw, David L Morris
BACKGROUND: No universally accepted guidelines exist for treatment of patients with colorectal cancer peritoneal metastases (CRPM) undergoing cytoreductive surgery and intraperitoneal chemotherapy (CRS/IPC). Several uncertainties remain concerning almost every aspect of this treatment modality, resulting in marked variability in patient management and likely outcomes. This survey aimed to define variations and trends in clinician decision making more clearly. METHODS: A 41-question web-based survey was distributed electronically via the Peritoneal Surface Oncology Group International (PSOGI), the International Society for the Study of Pleura and Peritoneum (ISSPP) as well as via social media (particularly Twitter)...
April 5, 2023: Annals of Surgical Oncology
keyword
keyword
76269
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.